Latest News
Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-cell Vaccine
Results Mark Third Successful Phase II Study With ToleroMune T-Cell Vaccines
12 February 2010
Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite and Cat Allergies
19 January 2010
Circassia announces successful results from phase II clinical study of ToleroMune cat allergy therapy
Study Identifies Optimal Treatment Approach For Late-Stage Development
20 November 2009
Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
New ToleroMune treatment extends clinical-stage portfolio
13 May 2009
Did you know?
The average bed could be home to up to 1.5 million house dust mites